COFCO Biotechnology Co

COFCO Biotechnology Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of COFCO Biotechnology Co (000930.SZ) as of Nov 3, 2026 is 0.85 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 0.41 % — a change of 106.38% (higher).

EBIT/Assets

0.85 %

YoY

106.38%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of COFCO Biotechnology Co is 2025 0.85 % . Operating Income to Assets Ratio (EBIT/Assets) of COFCO Biotechnology Co was 2024 0.41 % . It decreases by 106.38% higher compared to the previous year.

The COFCO Biotechnology Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
3.85 CNY
Jan 1, 2019
4.76 CNY
Jan 1, 2020
3.94 CNY
Jan 1, 2021
8.42 CNY
Jan 1, 2022
7.87 CNY
Jan 1, 2023
-3.46 CNY
Jan 1, 2024
0.41 CNY
Jan 1, 2025
0.85 CNY
The COFCO Biotechnology Co EBIT/Assets history
YEAREBIT/AssetsYoY
0.85 %+106.38%
0.41 %-111.94%
-3.46 %-143.92%
7.87 %-6.50%
8.42 %+113.87%
3.94 %-17.34%
4.76 %+23.76%
3.85 %-77.01%
16.74 %+210.75%
5.39 %-119.66%
-27.40 %+3,194.15%
-0.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

COFCO Biotechnology Co Stock analysis

What does COFCO Biotechnology Co do? COFCO Biotechnology Co., Ltd. generates revenue through the production and sale of fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate along with their by-products. The company's main product lines include fuel ethyl alcohol products, citric acid products and their salts, amino acid products, edible oil, and L-lactic acid products, which are distributed domestically and internationally. Domestic markets and overseas markets are the primary segments purchasing these products, with the company focusing on both industrial and consumer applications of its chemical and food-grade outputs. The firm's product portfolio spans multiple sectors including biofuels, food additives, and industrial chemicals, serving various industries through its diverse range of offerings. The company's revenue streams are derived from the sale of its core products such as fuel ethanol, citric acid, and amino acid derivatives, which are sold to industrial clients and food manufacturers. By-products from these production processes are also sold, enhancing overall profitability. The domestic market remains a key sales channel, while international distribution supports growth in overseas regions, particularly where demand for bio-based products is rising. COFCO Biotechnology leverages its production capabilities to serve both local and global customers with consistent product quality and supply. COFCO Biotechnology's business model centers on manufacturing and distributing a wide array of chemical and food-related products. Its primary customers are industrial buyers seeking raw materials for biofuel production, food processing, and chemical manufacturing. The company's product mix includes high-demand items like fuel ethanol for energy applications and citric acid for food and pharmaceutical uses. By maintaining a strong presence in both domestic and international markets, the company ensures steady revenue from multiple product lines and geographic segments. COFCO Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about COFCO Biotechnology Co stock

Operating Income to Assets Ratio (EBIT/Assets) of COFCO Biotechnology Co is 0.85 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of COFCO Biotechnology Co changed from 0.41 % to 0.85 %, representing a 106.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) COFCO Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s COFCO Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — COFCO Biotechnology Co

All Key Metrics — COFCO Biotechnology Co